We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer.
- Authors
Cannistra, Stephen A; Matulonis, Ursula A; Penson, Richard T; Hambleton, Julie; Dupont, Jakob; Mackey, Howard; Douglas, Jeffrey; Burger, Robert A; Armstrong, Deborah; Wenham, Robert; McGuire, William
- Abstract
We evaluated the efficacy and safety of bevacizumab in patients with platinum-resistant epithelial ovarian carcinoma (EOC) or peritoneal serous carcinoma (PSC) who had experienced disease progression during, or within 3 months of discontinuing, topotecan or liposomal doxorubicin.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Vol 25, Issue 33, p5180
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2007.12.0782